- Home
- LI vs CRL Comparison
LI vs CRL Comparison
Compare LI & CRL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | CRL |
|---|---|---|
| Founded | 2015 | 1947 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.4B | 10.8B |
| IPO Year | 2019 | 1999 |
Fundamental Metrics
Financial Performance| Metric | LI | CRL |
|---|---|---|
| Price | $12.34 | $280.05 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 12 |
| Target Price | $19.66 | ★ $198.27 |
| AVG Volume (30 Days) | ★ 3.4M | 883.5K |
| Earning Date | 05-28-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,857,601,000.00 |
| Revenue This Year | $18.98 | N/A |
| Revenue Next Year | $22.72 | $3.04 |
| P/E Ratio | $29.50 | ★ N/A |
| Revenue Growth | N/A | ★ 10.48 |
| 52 Week Low | $11.65 | $144.26 |
| 52 Week High | $26.94 | $288.02 |
Technical Indicators
Market Signals| Indicator | LI | CRL |
|---|---|---|
| Relative Strength Index (RSI) | 41.51 | 74.48 |
| Support Level | $12.06 | $153.47 |
| Resistance Level | $12.39 | N/A |
| Average True Range (ATR) | 0.29 | 9.39 |
| MACD | -0.05 | 3.21 |
| Stochastic Oscillator | 4.85 | 84.23 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is one of China's leading new energy vehicle manufacturers. Founded in 2015, the company designs, develops, manufactures, and sells premium smart NEVs with a particular focus on family size premium SUVs and MPVs. Li Auto started volume production of its first model—the Li One, an SUV that is a premium plug-in electric vehicle- in November 2019. Besides PHEVs, its product portfolio now extends to EVs that are fully battery-powered, reaching a wide audience. It has sold over 400,000 NEVs in 2025, accounting for about 3% of China's passenger NEV market.
About CRL Charles River Laboratories International Inc.
Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.